UCIR

UCIR helps patients with cancer understand their #cancer #immunotherapy treatment. We provide easy-to-understand explanations on these new therapies and drugs.

[UCIR @UCIR_org]

New in Nature Medicine: researchers may have found why some myeloma patients get severe gut inflammation after BCMA CAR-T.
👉 CAR-T cells can linger in the intestine and inflammation ramps up. A JAK inhibitor helped 2 patients in early findings. #CART #MultipleMyeloma

[UCIR @UCIR_org]

New research from Mount Sinai: patients 80+ with early-stage lung cancer can safely undergo surgery with outcomes comparable to younger patients. Age alone shouldn't determine who gets a chance at a cure. (The Lancet Regional Health – Americas) https://t.co/dbms4QkeZp

[UCIR @UCIR_org]

CAR T-cell therapy is being tested in more types of childhood cancers - not just blood cancers, but also in brain tumors and solid tumors. 🎗 Learn how it works 👉 https://t.co/QPW5YrqeVg ️#ChildhoodCancerAwareness #Immunotherapy #CARTcells

[UCIR @UCIR_org]

A study shows that the genes we inherit from birth don’t just affect our risk of cancer. They can also shape how tumors interact with the immune system. It could explain why some people respond well to cancer immunotherapy while others don’t.
Read more 👉 https://t.co/AXzgLduWd2

[UCIR @UCIR_org]

Did you know that T cell receptors play a crucial role in our immune system? These tiny proteins help identify and fight off infections and cancer cells. Without them, our bodies would be defenseless. https://t.co/ZprsgVir4B #Tcellreceptors #ImmuneSystem

[UCIR @UCIR_org]

Think you know all about T cells? Think again. Here's the deal: there are THREE main types - cytotoxic, helper, and regulatory. Let's dive in and learn more with UCIR => https://t.co/ZprsgVir4B! #Tcells #immunology #science

[UCIR @UCIR_org]

Attention all healthcare professionals! Discover how our immune system can be harnessed to fight cancer. Visit our booth at #ONS50. We are looking forward to discussing the future of patient care with you. See you there! #CancerCare #ONSCongress

[UCIR @UCIR_org]

Unleashing the power of our own immune system to fight cancer is no longer a dream. CAR T cell therapy has revolutionized cancer treatment with its latest advancements. Explore CAR T cell therapy 👉 https://t.co/QPW5YrqeVg #cancer #CARTcell #advancements

[UCIR @UCIR_org]

Did you know that recent clinical trials have revealed groundbreaking innovations in immunotherapy protocols? From personalized treatments to combination therapies, the future of fighting cancer is looking brighter than ever. #immunotherapy #clinicaltrials #innovation

[UCIR @UCIR_org]

Behind every successful cancer treatment is a hidden truth - the power of our own immune system. With constant progress in cancer immunotherapy, scientists are unlocking its potential to fight back against this deadly disease. #CancerImmunotherapy #HopeForACure 🎗️

[UCIR @UCIR_org]

#WorldCancerDay – At UCIR, we keep patients informed with the latest research so they can make the best choices for their care. But access to reliable info & treatment isn’t equal for all.
💡 Let’s work together to close the care gap—because everyone deserves a fighting chance.

[UCIR @UCIR_org]

What makes some kidney cancers shrink dramatically with immunotherapy? 🌟 Scientists have uncovered key factors behind these extraordinary responses, offering hope for better treatments. Learn more about this breakthrough study! #KidneyCancer
https://t.co/AeehYE6B51

[UCIR @UCIR_org]

Recent clinical trial shows hope for patients with locally advanced bladder cancer https://t.co/rGN6meqQ2A #BladderCancer #ClinicalTrials

[UCIR @UCIR_org]

It is generally recommended to avoid administration of immune checkpoint inhibitors (ICIs) during pregnancy. More details here 👇 https://t.co/JcxTkuux17

[UCIR @UCIR_org]

Dr. Cercek and Dr. Diaz want people with rectal cancer tumors that are MMRd to know the clinical trial continues to enroll patients and is growing. https://t.co/PpFnxNfHNE #RectalCancer #Immunotherapy #ClinicalTrials

[UCIR @UCIR_org]

New research shows that tumors use prostaglandin E2 to communicate with immune cells. This interaction could potentially affect how the immune system responds to cancer, which is a crucial finding in understanding how tumors evade detection and develop. https://t.co/itp6WzSfdV

[UCIR @UCIR_org]

Using genetic engineering techniques, investigators have designed a novel type of cell, called Co-STAR, to recognize and fight cancer. https://t.co/0nnsmI9T2G

[UCIR @UCIR_org]

The FDA approved pembrolizumab (Keytruda) with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary advanced or recurrent endometrial carcinoma. #EndometrialCancer https://t.co/1AIiZafSCs

[UCIR @UCIR_org]

The role of genetic testing in cancer immunotherapy https://t.co/MDHSjeZwYi

[UCIR @UCIR_org]

New genetic test may predict response to immunotherapy in triple-negative breast cancer https://t.co/dKNHKIh71t